Targeting Parkin-regulated metabolomic change in cartilage in the treatment of osteoarthritis

  • Yiyang Ma
  • , Yidan Pang
  • , Ruomu Cao
  • , Zhikai Zheng
  • , Kaiwen Zheng
  • , Yucheng Tian
  • , Xiaoyuan Peng
  • , Delin Liu
  • , Lin Du
  • , Zhigang Zhong
  • , Lufeng Yao
  • , Changqing Zhang
  • , Jun jie Gao

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Articular cartilage degeneration may lead to osteoarthritis (OA) during the aging process, but its underlying mechanism remains unknown. Here, we found that chondrocytes exhibited an energy metabolism shift from glycolysis to oxidative phosphorylation (OXPHOS) during aging. Parkin regulates various cellular metabolic processes. Reprogrammed cartilage metabolism by Parkin ablation decreased OXPHOS and increased glycolysis, with ameliorated aging-related OA. Metabolomics analysis indicated that lauroyl-L-carnitine (LLC) was decreased in aged cartilage, but increased in Parkin-deficient cartilage. In vitro, LLC improved the cartilage matrix synthesis of aged chondrocytes. In vivo, intra-articular injection of LLC in mice with anterior cruciate ligament transaction (ACLT) ameliorated OA progression. These results suggest that metabolic changes are regulated by Parkin-impaired cartilage during aging, and targeting this metabolomic changes by supplementation with LLC is a promising treatment strategy for ameliorating OA.
Original languageEnglish
Article number110597
Number of pages17
JournalIscience
Volume27
Issue number9
DOIs
Publication statusPublished - 20 Sept 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Targeting Parkin-regulated metabolomic change in cartilage in the treatment of osteoarthritis'. Together they form a unique fingerprint.

Cite this